Cytiva
Pall Life Sciences and Cytiva have united under the Cytiva name — forming a stronger global provider of technologies and services to advance and accelerate the development, manufacture, and delivery of therapeutics. We’re bringing together a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service to help researchers and biopharma advance therapeutics at every stage from discovery to delivery. Our combined heritage dating back hundreds of years better positions us to serve our customers. Researchers, academia, and biopharma undertake life-saving activities ranging from biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. We supply them with the tools and services they need to work better, faster, and safer, leading to better patient outcomes.
Company details
Find locations served, office locations and our distributors
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Employees:
- Over 1000
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Cytiva is part of Danaher, a global science and technology leader. Along with Danaher’s diagnostic and life sciences businesses, we accelerate the impact of innovation to help improve human health.
History
Designing in Sustainability
With Cytiva’s mission of advancing and accelerating therapeutics as our North Star, we have a sustainability plan to deliver on our impacts for people and our planet, and grow in the process.
- Learn how we are helping people thrive
- Discover how we are helping our planet thrive
- Explore how we are building a resilient business
Here’s our progress on ‘Designing in sustainability’ - our plan for impact.
- We are decoupling our impacts on the environment from our operations, even while we meet customers’ growing needs
- We are delivering lasting value for society, customers, associates, and other stakeholders
- Sustainability is helping us build a more resilient company
- Our mission to advance and accelerate therapeutics goes to the heart of our contribution to society
“73% of biological therapies (used for vaccinations and immune related disease treatments) that were newly approved in 2022 were supported by a solution from Cytiva.”
Since Earth Day, we’ve been offsetting the carbon emissions of shipping all online orders. We believe in working together to tackle climate change. This is one way we are reducing Cytiva’s carbon footprint.
To learn more about this program, click here.
Thriving people, thriving planet, a thriving business. For Cytiva, these three goals are deeply connected. Achieving them is our ambition and our responsibility. That’s why we commit to integrating respect for people and care of the environment in our decisions in ways that have a lasting impact.
Cytiva’s commitment to sustainability
United Nations Global Compact | Danaher Code of Conduct | Danaher Supplier Code of Conduct | Danaher Environmental, Health and Safety (EHS) | Privacy and Security | Danaher Policies and Statements
The Sustainable Development Goals (SDGs) are an important UN milestone that sets the scene for ending extreme poverty, fighting inequality and injustice and protecting the environment. It is a 17-point plan that charts society’s response to 2030. Cytiva has an opportunity to influence the outcomes of many of the SDGs by reducing the negative impacts of our operations, contributing to positive change along our value chain and engaging in society at large.
Biopharma Resilience
Our Biopharma Resilience Index is a deep-dive analysis of how the biopharma industry is performing across five key pillars: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation.
We surveyed 1250 biopharma and healthcare executives to understand the progress, challenges, and opportunities currently confronting the industry both globally and at a regional/country level. The index provides clear recommendations for how the industry could forge a more resilient future.
Celebrating Discovery
We’ve been celebrating discovery for almost 300 years - discovery that’s driven by the forever curious experts across our organization. And now, we’re shining the light on some of the world’s leading scientists to explore what drives them to make their amazing discoveries.